Pharmacokinetic and Pharmacodynamic Profiles of Extended Dosing of Epoetin Alfa in Anemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

Por McGowan, Tracy, Vaccaro, Nicole M., Beaver, Jessica S., Massarella, Joseph, Wolfson, Marsha
Publicado em 2008

A Randomized Study of Extended Dosing Regimens for Initiation of Epoetin Alfa Treatment for Anemia of Chronic Kidney Disease

Por Spinowitz, Bruce, Germain, Michael, Benz, Robert, Wolfson, Marsha, McGowan, Tracy, Tang, K. Linda, Kamin, Marc
Publicado em 2008

Pirfenidone Is Renoprotective in Diabetic Kidney Disease

Por RamachandraRao, Satish P., Zhu, Yanqing, Ravasi, Timothy, McGowan, Tracy A., Toh, Irene, Dunn, Stephen R., Okada, Shinichi, Shaw, Michael A., Sharma, Kumar
Publicado em 2009

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β...

Por Ziyadeh, Fuad N., Hoffman, Brenda B., Han, Dong Cheol, Iglesias-de la Cruz, M. Carmen, Hong, Soon Won, Isono, Motohide, Chen, Sheldon, McGowan, Tracy A., Sharma, Kumar
Publicado em 2000

Pirfenidone for Diabetic Nephropathy

Por Sharma, Kumar, Ix, Joachim H., Mathew, Anna V., Cho, Monique, Pflueger, Axel, Dunn, Stephen R., Francos, Barbara, Sharma, Shoba, Falkner, Bonita, McGowan, Tracy A., Donohue, Michael, RamachandraRao, Satish, Xu, Ronghui, Fervenza, Fernando C., Kopp, Jeffrey B.
Publicado em 2011